KAYLA HENSON: Open Payments
NPI 1164600466 · BENTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 41 payments from 11 companies in 2025. Trend: 2023 $370 · 2024 $689 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $145 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Astellas Pharma US Inc | 4 | $114 |
| Eisai Inc. | 4 | $109 |
| Phathom Pharmaceuticals, Inc. | 5 | $69 |
| Novo Nordisk Inc | 3 | $47 |
| PFIZER INC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: UBRELVY, Veozah, LEQVIO, Leqembi, VOQUEZNA, PREVNAR 20, Auvelity, GEMTESA.
Industry payments across KY — which companies pay providers there.
